Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Non-GAAP operating income (loss) by Quarter
Non-GAAP operating income (loss) ($M) ($M)
Gilead Sciences Non-GAAP operating income (loss): -$10,394M in Q2 2026, down 520.1% from a year earlier. That is the lowest of the 26 quarters on record here.
Where the Q2 2026 figure comes from
“|| Operating (loss) income | (10,394) | 2,474 | (7,808) | 4,711”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-08-04) ↗
Reported in Form 8-K GAAP to Non-GAAP Reconciliation.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Gilead Sciences Non-GAAP operating income (loss) ($M), quarterly Q1 2020–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-op-inc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.